About Modafinil Odin Pharmaceuticals
Modafinil is a eugeroic (wakefulness-promoting) pharmaceutical compound that functions as a weak dopamine reuptake inhibitor. Manufactured by Odin Pharmaceuticals, this preparation is supplied exclusively for controlled laboratory research examining neurotransmitter modulation pathways. Researchers at Stroid UK Shop investigate modafinil’s complex mechanisms involving dopaminergic, noradrenergic, histaminergic, and orexinergic systems. Unlike traditional stimulants, modafinil demonstrates selective activation of specific brain regions while exhibiting minimal effects on peripheral sympathetic nervous system markers in preclinical models. The compound has undergone extensive clinical evaluation for narcolepsy and shift work sleep disorder, making it a valuable reference standard for cognitive enhancement research.
Laboratory Applications
Research scientists study modafinil’s unique pharmacological profile for understanding sleep-wake cycle regulation and cognitive function enhancement mechanisms. The compound exhibits low abuse potential compared to traditional psychostimulants, making it suitable for investigating therapeutic alternatives in attention and alertness studies. Comparative research with selective androgen receptor modulators examines potential synergistic effects on physical performance markers. Additional investigations focus on modafinil’s neuroprotective properties and its interaction with various neurotransmitter systems. Laboratory protocols evaluate the compound’s effects on executive function, working memory, and decision-making processes in controlled research environments. Studies also examine modafinil’s influence on fatigue markers and sustained attention paradigms, particularly relevant for peptide research investigating cognitive enhancement pathways.
Technical Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | 2-[(Diphenylmethyl)sulfinyl]acetamide |
| Molecular Formula | C₁₅H₁₅NO₂S |
| Molecular Weight | 273.35 g/mol |
| CAS Number | 68693-11-8 |
| Purity | Verify with supplier |
| Storage | Room temperature, dry environment |
| Stability | Stable under recommended conditions |
| Research Classification | Eugeroic/Wakefulness promoter |
Compliance Statement
This Modafinil preparation from Odin Pharmaceuticals is intended strictly for in-vitro research purposes only. Not approved for human consumption, therapeutic use, or administration to living subjects. Researchers must maintain appropriate laboratory safety protocols and regulatory compliance when conducting studies with this compound. Purchase and use restrictions may apply based on local regulations governing research chemicals.
